Related Experiment Video
Updated: Aug 19, 2025

08:27
Photothrombosis-induced Focal Ischemia as a Model of Spinal Cord Injury in Mice
Published on: July 16, 2015
14.2K
Pyroptosis in spinal cord injury
Jian Yin1,2, Ge Gong3, Wenhui Wan3
1Department of Orthopedics, The Affiliated Jiangning Hospital With Nanjing Medical University, Nanjing, China.
Frontiers in Cellular Neuroscience
|December 5, 2022
Summary
Spinal cord injury (SCI) involves cell death pathways like pyroptosis, a pro-inflammatory regulated cell death (RCD). Targeting pyroptosis offers new therapeutic strategies for SCI recovery.
Area of Science:
- Neuroscience
- Cell Biology
- Immunology
Background:
- Spinal cord injury (SCI) causes irreversible neuronal and glial damage, initiating secondary injury cascades.
- Inflammatory mediators released during SCI exacerbate nerve damage.
- Pyroptosis, a pro-inflammatory regulated cell death (RCD) pathway mediated by caspases and executed by Gasdermins (like GSDMD), is implicated in CNS disorders.
Purpose of the Study:
- To review the evidence of pyroptosis in spinal cord injury (SCI).
- To focus on pyroptosis in different cell types within the CNS and their interactions during SCI.
- To discuss the interplay between pyroptosis and other RCDs in SCI and summarize therapeutic strategies.
Main Methods:
- Literature review of studies investigating pyroptosis in SCI.
- Analysis of the role of caspase-1/11 and Gasdermin D (GSDMD) in SCI pathogenesis.
- Examination of cellular crosstalk and interactions with other RCDs.
Main Results:
- Pyroptosis is a significant contributor to cell death and inflammation following SCI.
- Multiple CNS cell types, including neurons and glial cells, undergo pyroptosis.
- Crosstalk between pyroptotic cells and interactions with other RCDs are crucial in SCI progression.
Conclusions:
- Pyroptosis is a key mechanism in SCI pathogenesis, involving various CNS cell types.
- Understanding the complex interactions of pyroptosis and other RCDs is vital for developing effective treatments.
- Inhibition of pyroptosis presents a promising therapeutic avenue for improving outcomes after SCI.

